ARCHIVES

ODAC Rejects Amsacrine NDA, Renews Idarubicin

This article is from The Cancer Letter archive.

Vol. 16 No. 35 | September 14, 1990

Download PDF Visit The Full Archive

Related Articles

ACCC Planning Session Considers Community Impact

August 31, 1979

In Brief: Moloney, Manaher, 11 Other NCI Staff Members Retire; Terry Takes Leave From Immunology Jobs

March 7, 1980

Three Experimental Beamlines To Be Built For Research.

May 17, 2002

NIH To Replace RAC With New Committee

July 19, 1996

Deals and Collaborations: Firms Get First Payment From Bristol-Myers for Taxol

March 5, 1999

Senate Approves Appropriations Bill; GRH Threatens It

October 23, 1987